Neurol India Close
 

Figure 2: Kaplan–Meier survival analysis and survival distribution of patients in RT, RT + TMZ and BVC group. RT - Radiotherapy, RT + TMZ - Radiotherapy with concurrent temozolomide chemotherapy, BVC - Radiotherapy with concurrent temozolomide chemotherapy supplemented with bevacizumab after progression

Figure 2: Kaplan–Meier survival analysis and survival distribution of patients in RT, RT + TMZ and BVC group. RT - Radiotherapy, RT + TMZ - Radiotherapy with concurrent temozolomide chemotherapy, BVC - Radiotherapy with concurrent temozolomide chemotherapy supplemented with bevacizumab after progression